Polychronopoulos Vlasios

Polychronopoulos Vlasios Pulmonologist

Director, 1st Pulmonary Department HYGEIA Hospital

Education & Academic Qualifications

  • Scientific Staff, Pathophysiology Dpt: University Of Athens


  • Medical School, ATHENS University, 1975
  • Pulmonary Medicine, 1980
  • Occupational Lung Disease, 1988


Doctoral thesis

  • Lead exposure: Blood and Respiratory consequencies

Fellowship in Societies, Membership in Journal Editorial Committees

American College Of Chest Physician:

  • Governor For Greece: 2000-2015—

  • Scientific Presentation And Awards Committee:2005-2007-

  • Nominations Committee: 2003-2005

  • Educational Committee: 2000-2015

Ers Member

Editorial Boards:

AD-Hoc Reviewer for peer-reviewed international journals

  • Respiratory Medicine 

  • Sarcoidosis Vasculitis And Diffuse Lung Disease


Work Experience

  • Staff, 4th Resp.Dept.Sotiria Hospital:1981-1989

  • Director, Pulmonary Dpt, A.Fleming General Hospital, Athens: 1989-1997

  • Director,3rd Pulmonary Dpt, Sismanoglion General Hospital, Athens: 1997-2012

  • Director, 1st Pulmonary Clinic, HYGEIA General Hospital, Athens: 2016-

Education Experience:

  • Critical Care Department and Lung Function Laboratories, London Chest Hospital – Six months:(Sept1983- June 84, London U.K., supervisor Dr. R.M. Rudd)

  • Laser in Bronchoscopy-One week ( May 1988, Marseille France, supervisor Prof. Dumon and Prof. Shapshay)

  • Bronchoalveolar Lavage –One week-(1986, Prague Czechoslovakia, supervisor Prof. Voisin)

  • Bronchoscopy Chest Clinic- MayoClinic ;Three months:July – October 1996 – Supervisor : Prof. Prakash

  • Interstitial Lung Disease Unit: Brompton Royal Hospital-LONDON- Three months:January 1999-April1999

  • Pulmonary Vasculitis: Mayo Clinic-Three months;Prof. U.Specks:May 1st—July 31st 2007

  • Sarcoidosis: Medical University of South Carolina (MUSC)-Charleston, SC, Prof M. Jud-son.—Three months:August 1st-October 31st.


Clinical & Research Interest

  • Diffuse Lung Disease(Brompton Hospital-LONDON 1999—MAYO CLINIC 2007—-Medical University Of South Carolina 2007): Pulmonary Fibrosis –Sarcoidosis—Pulmonary Hemorrhage—

  • (Bronchoscopy: Mayo Clinic 1997

Research Interest:

  • Diffuse Lung Disease, Copd: See Below :Publications


Honors & Awards

  • Hellenic Thoracic Society: Copd Research Award 2006—Chest 2004


  • Clinical Pneumonology (3 volumes) edited by D. Polyzogopoulos and V. Polychronopou-los, 1993 pages : 2870-Paschalidis Editions

  • Physiology of the Lung, edited by V. Polychronopoulos, translated version of J.B. West “Respiratory Physiology”, 1987

  • Pathophysiology of the Lung, edited by V. Polychronopoulos, translated version of J.B. West “Pulmonary Pathophysiology”, 1986
    Atlas of Bronchoscopy, edited by G. Thalassinos and V. Polychronopoulos, translated version of P. Straddling

  • “Atlas of Bronchoscopy”,Paschalidis Editions: 1996

  • Chest and Cardiac Imaging, edited by V. Polychronopoulos, translated version of R. Ei-senberg “Chest and Cardiac Imaging “,Paschalidis Editions 1996

  • Pathophysiology in diffuse interstitial lung diseases (chapter). V. Polychronopoulos. In: Interstitial Lung Diseases, edited by Hellenic Thoracic Society, 1994

  • Metastatic lung neoplasms (chapter). V. Polycrhonopoulos. In: Bronchogenic Cancer, edited by Hellenic Thoracic Society, 1993

  • Unresolving Pneumonia (chapter). V. Polychronopoulos. In : Infectious Disease of the Lung, edited by Medical Association of Athens, 1990

  • Interpretation of lung function testing. V. Polychronopoulos. Edited by Hellenic Thoracic Society, 1991

  • Ventilation (chapter). V. Polychronopoulos. In: Pulmonary Physiology, edited by Hel-lenic Thoracic Society, 1991

  • Diagnostic and interventional bronchoscopy. Postgraduate Course, Hellenic Thoracic Society, 1996

  • Interstitial lung disease. V. Polychronopoulos. Postgraduate Course, Helliniki Iatriki, 63, sup. 3, 430-525, 1997

  • Organizing Pneumonia Hel. Thorac. Soc. 2004

  • Lung cancer: Classification. Hel. Thorac. Soc. 2004

  • Polychronopoulos V., Kosmas E. Pleural effusion secondary to Gastrointestinal Disease. In: Deckers Pleural Disease; Bouros D: 2004-and 2nd Edition 2008

  • Same as 15 : 3rd Edition ,2010

  • Clinical Pneumonology : 3 Volumes-Pages :3070 -Textbook:Edited by :D. Polyzogopoulos and V. Polychronopoulos-Paschalidis Editions-2005

  • Pulmonary Circulation.D.Polyzogopoulos-V. Polychronopoulos. In : Pulmonary Physiolo-gy-Edited by Hellenic Thoracic Society- 2006

  • Extrinsic Allergic Alveolitis :Diagnosis and differential diagnosis- V.Polychronopoulos-In: Occupational and Environmental Lung Diseases-Edited by Hellenic Thoracic Society-2007

  • Acute interstitial and alveolar infiltrates : V. Polychronopoulos-In: Emergency Chest Medicine: Edited by Hellenic Thoracic Society-2008

  • The Chest Physician evaluating the clinicolaboratory findings for the Diagnosis of In-terstitial Lung Disease;Polychronopoulos V and Stagaki H. In Hellenic Thoracic Society :Textbook for the Role of the Laboratory in the Evaluation of Lung Disease; Athens 2009.

  • Common questions in Chest Medicine;Hellenic Thoracic Society 2010: Essentials in Pulmonary Embolism.

  • Diffuse Alveolar Hemorrhage syndromes: chapter 15;E.Stagaki and V.Polychronopoulos;In:S.K.Jindal’s:Textbook of Pulmonary and Critical Care Medi-cine;JAYPEE Brothers;2010 -2nd Edition : JAYPEE Brothers; 2015

  • Airway involvement iILDs:S.Tryphon,V.Polychronopoulos,in: Interstitial Lung Disease;O.Sharma;ED.JAYPEE Brothers,2011 Acute Exacerbation of Sarcoidosis;In:.

  • Acute Exacerbation of Respiratory Disease: S.SAHN;ED. :JAYPEE Brothers,2011


Recent Publications

Recent Publications (till 10)—Citations: 1209(Aug 2015)

  • Terminal diffuse alveolar damage in relation to interstitial pneumonias. An autopsy study. 81 Citations –Aug 2014–Rice AJ, Wells AU, Bouros D, du Bois RM, Hansell DM, Poly-chronopoulos V, Vassilakis D, Kerr JR, Evans TW, Nicholson AG.–Am J Clin Pathol. 2003 May;119(5):709-14.

  • Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome.—349 Citations—Aug.2014–Bouros D, Wells AU, Nicholson AG, Colby TV, Polychronopoulos V, Pantelidis P, Haslam PL, Vassilakis DA, Black CM, du Bois RM.–Am J Respir Crit Care Med. 2002 Jun 15;165(12):1581-6.

  • Acute interstitial pneumonia.—96 Citations—Aug.2014–Bouros D, Nicholson AC, Poly-chronopoulos V, du Bois RM.–Eur Respir J. 2000 Feb;15(2):412-8. Review.

  • Long-term clinical effects of interferon gamma-1b and colchicine in idiopathic pulmonary fibrosis.—48 Citations—Aug 2014–Antoniou KM, Nicholson AG, Dimadi M, Malagari K, Latsi P, Rapti A, Tzanakis N, Trigidou R, Polychronopoulos V, Bouros D.–Eur Respir J. 2006 Sep;28(3):496-504. Epub 2006 Apr 12.

  • Organizing pneumonia.—-28 Citations—Aug.2014–Drakopanagiotakis F, Polychronopou-los V, Judson MA.Am J Med Sci. 2008 Jan;335(1):34-9. doi: 10.1097/MAJ.0b013e31815d829d. Review.

  • Apoptosis in lung injury and fibrosis.—40 Citations –Aug 2014Drakopanagiotakis F, Xifteri A, Polychronopoulos V, Bouros D.Eur Respir J. 2008 Dec;32(6):1631-8. doi: 10.1183/09031936.00176807. Review.

  • Airway involvement in sarcoidosis. 31 Citations Aug 2014–Polychronopoulos VS, Prakash UB.-CHEST. 2009 Nov;136(5):1371-80. doi: 10.1378/chest.08-

  • Concomitant sarcoidosis and a connective tissue disease: Review of the clinical findings and postulations concerning their association.-Judson MA, Freitas S, Polychronopoulos VS, Highland KB.–Resp. Med. Febr.2013

  • Respiratory and lower limb muscle function in interstitial lung disease.Panagiotou M1, Polychronopoulos V2, Strange C3–Chron Respir Dis. 2016 Jan 14

  • The Effect of Incidental Consolidation on Management and Outcomes in COPD Exacer-bations: Data from the European COPD Audit.–Saleh A, Lopez-Campos JL, Hartl S, Pozo-Rodriguez F,Roberts CM;PolychronopoulosV.et al: European COPD Audit team.– PLoS One. 2015 Jul 27;10(7)